SCHEMBL4981575

SCHEMBL4981575

OCCOCCOCCOc1cc[c]cc1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
APP P05067 10/20 0.53
MAPK1 P28482 3/20 0.49
ALDH1A1 P00352 2/20 0.49
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
USP2 O75604 1/20 0.49
LMNA P02545 1/20 0.49
CYP3A4 P08684 1/20 0.49
CASP1 P29466 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
SLCO1B3 Q9NPD5 1/20 0.49
SLCO1B1 Q9Y6L6 1/20 0.49
RECQL P46063 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.46
TSHR P16473 1/20 0.40
NR1I2 O75469 1/20 0.39
KDM4E B2RXH2 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
GAA P10253 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16346124 1.00 APP (0.53) APPMAPK1ALDH1A1MEN1KMT2A
SCHEMBL17627814 1.00 APP (0.53) APPMAPK1ALDH1A1MEN1KMT2A
SCHEMBL768675 1.00 APP (0.53) APPMAPK1ALDH1A1MEN1KMT2A
SCHEMBL348921 0.87 ALDH1A1 (0.60) APPMAPK1ALDH1A1MEN1KMT2A
SCHEMBL8809033 0.87 ALDH1A1 (0.42) APPMAPK1ALDH1A1MEN1KMT2A
SCHEMBL24303208 0.85 APP (0.67) APPMAPK1ALDH1A1MEN1KMT2A
SCHEMBL3085759 0.85 APP (0.67) APPMAPK1ALDH1A1MEN1KMT2A
SCHEMBL7651553 0.84 APP (0.53) APPMAPK1KDM4ETDP1
SCHEMBL466232 0.83 APP (0.65) APPMAPK1ALDH1A1MEN1KMT2A
SCHEMBL10785918 0.82 KCNA3 (0.43) MAPK1ALDH1A1RECQLKDM4ETDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3740493-B1 INHIBTEURS DE L'INDOLEAMINE 2,3-DIOXYGÉNASE ET/OU DU TRYPTOPHANE DIOXYGÉNASE IDORSIA PHARMACEUTICALS LTD (CH) 2021-12-01 EP claimed
US-20200405696-A1 INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND/OR TRYPTOPHAN 2,3-DIOXYGENASE IDORSIA PHARMACEUTICALS LTD (CH) 2020-12-31 US claimed
EP-3740493-A1 INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND/OR TRYPTOPHAN 2,3-DIOXYGENASE Idorsia Pharmaceuticals Ltd (CH) 2020-11-25 EP claimed
EP-3740493-B1 INHIBTEURS DE L'INDOLEAMINE 2,3-DIOXYGÉNASE ET/OU DU TRYPTOPHANE DIOXYGÉNASE IDORSIA PHARMACEUTICALS LTD (CH) 2021-12-01 EP disclosed
US-20200405696-A1 INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND/OR TRYPTOPHAN 2,3-DIOXYGENASE IDORSIA PHARMACEUTICALS LTD (CH) 2020-12-31 US disclosed
EP-3740493-A1 INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND/OR TRYPTOPHAN 2,3-DIOXYGENASE Idorsia Pharmaceuticals Ltd (CH) 2020-11-25 EP disclosed
CN-110177677-A three-dimensional printing 惠普发展公司,有限责任合伙企业 2019-08-27 CN disclosed
CN-110036102-A The method of cleaning compositions and cleaning equipment 凯米罗总公司 2019-07-19 CN disclosed
CN-108913054-A A kind of dedicated optics rupture pressure disc of high viscosity Curved screen 苏州袭麟光电科技产业有限公司 2018-11-30 CN disclosed
CN-108893072-A A kind of antistatic super abrasive optical protection layer 苏州袭麟光电科技产业有限公司 2018-11-27 CN disclosed
CN-104884601-B Dress material liquid cleanser composition 花王株式会社 2018-02-13 CN disclosed
US-20070048467-A1 Information recording medium HITACHI MAXELL, LTD. 2007-03-01 US disclosed
EP-1249488-A1 Softener composition Kao Corporation (JP) 2002-10-16 EP disclosed
US-6023130-A Plasma display substrate and a production method thereof KYOCERA CORPORATION (JP) 2000-02-08 US disclosed
EP-0476456-B1 Substituted 2-thiazolyl tetrazolium salt indicators BAYER AG (US) 1997-11-12 EP disclosed
EP-0476457-B1 2-Benzothiazolyl tetrazolium salt indicators BAYER AG (US) 1996-12-04 EP disclosed
EP-0476454-B1 Analytical method using tetrazolium salt indicators having a reflectance plateau BAYER AG (US) 1996-10-23 EP disclosed
US-5322680-A Chromogenic detector for medical diagnosis by forming formazan dyes chemical reduction MILES INC. (US) 1994-06-21 US disclosed
US-5300637-A Useful in determination of reducing substances MILES INC. (US) 1994-04-05 US disclosed
US-5126275-A Chromogenic reducing indicators for reducing substances such as NADH MILES INC. (US) 1992-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200405696-A1 INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND/OR TRYPTOPHAN 2,3-DIOXYGENASE IDO2, TDO2, IDO1 APP 4445/4885MAPK1 3817/4885ALDH1A1 631/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.